Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Accumulated Depreciation & Amortization (2020 - 2024)

Historic Accumulated Depreciation & Amortization for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $88949.0.

  • Immuneering's Accumulated Depreciation & Amortization rose 1360.9% to $88949.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $88949.0, marking a year-over-year increase of 1360.9%. This contributed to the annual value of $322816.0 for FY2023, which is 2283.35% down from last year.
  • As of Q3 2024, Immuneering's Accumulated Depreciation & Amortization stood at $88949.0, which was up 1360.9% from $90533.0 recorded in Q2 2024.
  • Immuneering's Accumulated Depreciation & Amortization's 5-year high stood at $418337.0 during Q4 2022, with a 5-year trough of $54560.0 in Q2 2022.
  • For the 5-year period, Immuneering's Accumulated Depreciation & Amortization averaged around $146551.1, with its median value being $90533.0 (2024).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 14012.13% in 2022, then crashed by 6551.64% in 2023.
  • Quarter analysis of 5 years shows Immuneering's Accumulated Depreciation & Amortization stood at $128752.0 in 2020, then soared by 35.31% to $174219.0 in 2021, then surged by 140.12% to $418337.0 in 2022, then decreased by 22.83% to $322816.0 in 2023, then tumbled by 72.45% to $88949.0 in 2024.
  • Its last three reported values are $88949.0 in Q3 2024, $90533.0 for Q2 2024, and $90209.0 during Q1 2024.